These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31307024)

  • 1. Cone-beam computed tomography-based delta-radiomics for early response assessment in radiotherapy for locally advanced lung cancer.
    Shi L; Rong Y; Daly M; Dyer B; Benedict S; Qiu J; Yamamoto T
    Phys Med Biol; 2020 Jan; 65(1):015009. PubMed ID: 31307024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feature selection methodology for longitudinal cone-beam CT radiomics.
    van Timmeren JE; Leijenaar RTH; van Elmpt W; Reymen B; Lambin P
    Acta Oncol; 2017 Nov; 56(11):1537-1543. PubMed ID: 28826307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.
    Qin Q; Shi A; Zhang R; Wen Q; Niu T; Chen J; Qiu Q; Wan Y; Sun X; Xing L
    Thorac Cancer; 2020 Apr; 11(4):964-972. PubMed ID: 32061061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence.
    van Timmeren JE; van Elmpt W; Leijenaar RTH; Reymen B; Monshouwer R; Bussink J; Paelinck L; Bogaert E; De Wagter C; Elhaseen E; Lievens Y; Hansen O; Brink C; Lambin P
    Radiother Oncol; 2019 Jul; 136():78-85. PubMed ID: 31015133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of cone beam CT in the adaptive radiotherapy planning process for non-small-cell lung cancer patients.
    Duffton A; Harrow S; Lamb C; McJury M
    Br J Radiol; 2016 Jun; 89(1062):20150492. PubMed ID: 27052681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of SBRT response in liver cancer by combining original and delta cone-beam CT radiomics: a pilot study.
    Yang P; Shan J; Ge X; Zhou Q; Ding M; Niu T; Du J
    Phys Eng Sci Med; 2024 Mar; 47(1):295-307. PubMed ID: 38165634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images.
    van Timmeren JE; Leijenaar RTH; van Elmpt W; Reymen B; Oberije C; Monshouwer R; Bussink J; Brink C; Hansen O; Lambin P
    Radiother Oncol; 2017 Jun; 123(3):363-369. PubMed ID: 28506693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer.
    Fave X; Zhang L; Yang J; Mackin D; Balter P; Gomez D; Followill D; Jones AK; Stingo F; Liao Z; Mohan R; Court L
    Sci Rep; 2017 Apr; 7(1):588. PubMed ID: 28373718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of lung density changes after radiotherapy by cone beam computed tomography response markers and pre-treatment factors for non-small cell lung cancer patients.
    Bernchou U; Hansen O; Schytte T; Bertelsen A; Hope A; Moseley D; Brink C
    Radiother Oncol; 2015 Oct; 117(1):17-22. PubMed ID: 26255762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and evolution of imaging changes on cone-beam CT during and after radical radiotherapy for non-small cell lung cancer.
    Clarke E; Curtis J; Brada M
    Radiother Oncol; 2019 Mar; 132():121-126. PubMed ID: 30825960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cone-beam computed-tomography-based delta-radiomic analysis for investigating prognostic power for esophageal squamous cell cancer patients undergoing concurrent chemoradiotherapy.
    Nakamoto T; Yamashita H; Jinnouchi H; Nawa K; Imae T; Takenaka S; Aoki A; Ohta T; Ozaki S; Nozawa Y; Nakagawa K
    Phys Med; 2024 Jan; 117():103182. PubMed ID: 38086310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locoregional control of non-small cell lung cancer in relation to automated early assessment of tumor regression on cone beam computed tomography.
    Brink C; Bernchou U; Bertelsen A; Hansen O; Schytte T; Bentzen SM
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):916-23. PubMed ID: 24867537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can radiomics features be reproducibly measured from CBCT images for patients with non-small cell lung cancer?
    Fave X; Mackin D; Yang J; Zhang J; Fried D; Balter P; Followill D; Gomez D; Jones AK; Stingo F; Fontenot J; Court L
    Med Phys; 2015 Dec; 42(12):6784-97. PubMed ID: 26632036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients.
    Knap MM; Hoffmann L; Nordsmark M; Vestergaard A
    Acta Oncol; 2010 Oct; 49(7):1077-84. PubMed ID: 20831499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of feature selection methods and subgroup factors on prognostic analysis with CT-based radiomics in non-small cell lung cancer patients.
    Sugai Y; Kadoya N; Tanaka S; Tanabe S; Umeda M; Yamamoto T; Takeda K; Dobashi S; Ohashi H; Takeda K; Jingu K
    Radiat Oncol; 2021 Apr; 16(1):80. PubMed ID: 33931085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cone-beam computed tomography for lung cancer - validation with CT and monitoring tumour response during chemo-radiation therapy.
    Michienzi A; Kron T; Callahan J; Plumridge N; Ball D; Everitt S
    J Med Imaging Radiat Oncol; 2017 Apr; 61(2):263-270. PubMed ID: 27804280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cone-beam CT-guided radiotherapy in the management of lung cancer: Diagnostic and therapeutic value.
    Elsayad K; Kriz J; Reinartz G; Scobioala S; Ernst I; Haverkamp U; Eich HT
    Strahlenther Onkol; 2016 Feb; 192(2):83-91. PubMed ID: 26630946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Primary Tumor Volume Changes on kV-CBCT during Definitive Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer.
    Wald P; Mo X; Barney C; Gunderson D; Haglund AK; Bazan J; Grecula J; Chakravarti A; Williams T; Carbone DP; Xu-Welliver M
    J Thorac Oncol; 2017 Dec; 12(12):1779-1787. PubMed ID: 28843360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
    Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
    Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep segmentation networks predict survival of non-small cell lung cancer.
    Baek S; He Y; Allen BG; Buatti JM; Smith BJ; Tong L; Sun Z; Wu J; Diehn M; Loo BW; Plichta KA; Seyedin SN; Gannon M; Cabel KR; Kim Y; Wu X
    Sci Rep; 2019 Nov; 9(1):17286. PubMed ID: 31754135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.